Navigation Links
Medco to Advance Cancer Care with Personalized and Specialized Treatment for Oncology Patients
Date:1/20/2010

re weak inhibitors of the liver enzyme CYP2D6.  The weak inhibitors of the enzyme include Celexa® (citalopram), Lexapro® (escitalopram), and Luvox® (fluvoxamine).
  • Evidence indicates that physicians have adjusted prescribing habits after the FDA published alerts and inserted boxed warnings into product labels for Erythropoiesis Stimulating Agents (ESAs) in 2007.  This resulted in a reduction in the spend for these agents.  Additional studies are planned to determine if this decrease led to any change in ER visits or hospitalizations for this group of patients.
  • Assessment of patients with chronic myeloid leukemia should include testing for the BCR-ABL gene and its product.  Physicians are not conducting necessary follow-up gene testing for Gleevec patients to determine whether the treatment is working.  Only 14 percent of patients had the BCR-ABL gene measured for consecutive quarters.  Only 60 percent had evidence of having one gene test performed at any period over 1.5 years.

  • For more information about Medco's research, please visit www.medcoresearch.com.

    About Medco

    Medco Health Solutions, Inc. (NYSE: MHS) is pioneering the world's most advanced pharmacy® and its clinical research and innovations are part of Medco making medicine smarter™ for more than 60 million members.

    With more than 20,000 employees dedicated to improving patient health and reducing costs for a wide range of public and private sector clients, and 2008 revenue exceeding

    SOURCE Medco Health Solutions, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Medco to Present at Upcoming Investor Conferences
    2. Medco Partners with AmeriCares to Rush Donated Medicines to Help Victims of the Haiti Earthquake
    3. Medco, State of Illinois and Community Retail Pharmacies Launch Wired Collaborative Solution to Close Critical Medication-Related Gaps in Healthcare, Improving Outcomes and Lowering Costs
    4. Medco Reforming Healthcare with Smarter Medicine; Wired, Transformational Pharmacy Model Advances Clinical Quality and Lowers Cost
    5. Medco Delivers Record Third-Quarter 2009 GAAP Diluted EPS of $0.69; Diluted EPS Excluding Amortization of Intangible Assets of $0.75
    6. Medco to Present at November 2009 Investor Conferences
    7. The Medco Foundation Joins With the Entertainment Industry Foundation to Give Health a Hand to Communities in Need
    8. Medcos 2010 Medicare Prescription Drug Plan Helps People Take an Active Part in Lowering Prescription Costs
    9. Medco Announces Date for Third-Quarter 2009 Financial Results; Company to Provide 2010 Earnings Guidance
    10. New White Paper Examines Advanced Mycoplasma Tests - How Real-Time PCR Analysis Helps Save Time and Money for Biopharmaceutical Manufacturers
    11. PTC Therapeutics Announces Additional Study of Ataluren in Patients with Advanced Nonsense Mutation Duchenne/Becker Muscular Dystrophy
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/16/2014)... Sept. 16, 2014  DNAtrix, Inc., experts in ... patient was treated with the company,s lead product, ... in a randomized, multicenter, open-label Phase Ib study ... in collaboration with leading neurosurgeons and neuro-oncologists in ... of our randomized Phase Ib study of DNX-2401 ...
    (Date:9/16/2014)... 2014  Eli Lilly and Company (NYSE: ... agreement to co-develop and commercialize AZD3293, an oral ... development as a potential treatment for Alzheimer,s disease. ... characterized by the accumulation of amyloid plaque in ... the development of beta-amyloid. Inhibiting BACE is expected ...
    (Date:9/15/2014)... WHIPPANY, N.J. , Sept. 16, 2014 /PRNewswire/ ... based in Espoo, Finland , ... III trial with ODM-201, an investigational oral androgen ... ARAMIS, evaluates ODM-201 in men with castration-resistant prostate ... levels and no detectable metastases. The trial is ...
    Breaking Medicine Technology:DNAtrix Announces Treatment Of First Patient With DNX-2401 In Recurrent Glioblastoma Trial 2Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 2Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 3Lilly and AstraZeneca announce alliance to co-develop potential treatment for Alzheimer's disease 4Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 2Bayer and Orion Initiate Phase III Trial of ODM-201 in Men with High-Risk Non-Metastatic Castration-Resistant Prostate Cancer 3
    ... and KOS, Greece, June 29, 2007 /PRNewswire/ --,The ... treated patients on REVLIMID (lenalidomide) plus the,steroid dexamethasone ... The data are pooled from two large randomized,controlled ... patients,from nearly 100 clinical sites worldwide. These updated ...
    ... at the 11th International Myeloma Workshop ... of perifosine in,combination with bortezomib, dexamethasone ... relapsed/refractory multiple,myeloma, and as a single ... NEW YORK, June 29, 2007 /PRNewswire-FirstCall/ ...
    Cached Medicine Technology:The European Myeloma Platform Reports New Survival data for,Revlimid Presented at the International Myeloma Workshop in Greece 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 2Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 3Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 4Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 5Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 6Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase,II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple,Myeloma and Waldenstrom's Macroglobulinemia 7
    (Date:9/16/2014)... the year for the latest science in the field. ... Care Association (ACCA) of the European Society of Cardiology ... , Monday 16 September 2014 Sophia Antipolis, France ... dealing with acute problems in need of urgent care ... The scientific programme is available here . , ...
    (Date:9/16/2014)... This news release is available in French . ... of a healthy diet and dietary guidelines recommend the daily ... yogurt, cheese, cream and butter. , It,s well ... bones, but new research has shown that dairy consumption may ... risk of metabolic diseases such as obesity and type 2 ...
    (Date:9/16/2014)... Angeles, CA (PRWEB) September 16, 2014 According ... NFL player David Wilson has retired after aggravating a neck ... disc, and was then discovered to have spinal stenosis as ... affects many adults and can lead to symptoms such as ... could play again after surgery to repair the disc, but ...
    (Date:9/16/2014)... NEW YORK (PRWEB) September 16, 2014 Today ... announced that its annual “Festive Evening of Song,” featuring luminary ... will take place on Monday, September 29, 2014 at the ... in Tarrytown, New York. The FSH Society is proud to ... event aimed at raising funds for FSHD research. , FSHD, ...
    (Date:9/16/2014)... (PRWEB) September 16, 2014 According to ... leading global authority in medical device market research, the ... over $750 million in the U.S . and ... initial PEG placement kits, PEG replacement tubes, DPEJ tubes, ... segmented into low-profile balloon tubes, low-profile non-balloon tubes, nasogastric ...
    Breaking Medicine News(10 mins):Health News:ACCA congress: Ensuring a rapid response to cardiac emergencies 2Health News:ACCA congress: Ensuring a rapid response to cardiac emergencies 3Health News:More cheese, please! News study shows dairy is good for your metabolic health 2Health News:NFL Injuries Put Spotlight on Spinal Health 2Health News:NFL Injuries Put Spotlight on Spinal Health 3Health News:Pianist Steven Blier and Grammy Award-Winner Sylvia McNair to Perform Together for FSH Society Benefit 2Health News:Pianist Steven Blier and Grammy Award-Winner Sylvia McNair to Perform Together for FSH Society Benefit 3Health News:Over 17 Million Enteral Feeding Device Placement Procedures is Expected to be Performed in the U.S. and Europe in 2020: Market Led by Covidien, Kimberly-Clark and Abbott 2Health News:Over 17 Million Enteral Feeding Device Placement Procedures is Expected to be Performed in the U.S. and Europe in 2020: Market Led by Covidien, Kimberly-Clark and Abbott 3
    ... Dana-Farber Cancer Institute in Boston, Massachusetts has come out ... monitored, prescribed and// coordinated in a better way. ... the institutes that participated in the research, Dr Lawrence ... the importance of forging a consensus in the oncology ...
    ... Canadian Institute of Health Research, in collaboration with Heart ... and women react// differently to medications for their heart ... by Canadian GENESIS project, men's ailing hearts respond differently ... Angiograms, which are usually effective in pinpointing heart problems ...
    ... the onset of dementia”, claims a research report. This study ... Toronto, Canada on 184 elderly patients. ... remaining spoke only one language. The average age in the ... was 71.4 in the other group. The study had considered ...
    ... you looking for simple ways to improve your heart health? ... or sprinkled throughout your day, may be one easy and// ... almonds continues to show why including a handful of almonds ... a look at what they are finding. ,Almonds ...
    ... specific health care should be provided for British Muslims. Professor ... the key for better health for Muslims in United Kingdom. ... Journal, professor reiterates the need for academicians, doctors and policy ... in the existing system. ,A provision for ...
    ... heart disease is a two-way street: Poor sleep can ... sleep, reports the January 2007// issue of the Harvard ... with high blood pressure, atherosclerosis, heart failure, heart attack ... these together may be inflammation, the body’s response to ...
    Cached Medicine News:Health News:Watchdog to Be Set on Oral Chemotherapy, Warns Experts 2Health News:Be True to Your Heart With a Handful of Almonds 2Health News:Be True to Your Heart With a Handful of Almonds 3
    Our most popular saline breast implant style for over 20 years. A full, rounded look that adds greater dimension to the breast....
    This Implant enhances and restores the nasal contour, The large selection of sizes with a variety of flares and lengths allows for more individualized results...
    Inquire...
    ... at the point of care: , Only 120 ... only 70 L of whole blood (all parameters except ... of sensor cassette , safePICO mixer ensures thorough and ... in 7 seconds) * Not ...
    Medicine Products: